BTK and B-cell chronic lymphocytic leukemia: Allogeneic stem cell transplantation is a possibility for fit patients in the treatment of CLL, but given the efficacy of targeted therapies, it is generally considered only after prior lines of therapy with BTK inhibitor- and venetoclax-based regimens [4].